logo
Select company
Select metric
$ 18.58MNet Cash Flow - Issuance (Purchase) of Equity Shares
VS
Market
17
Sector
28
Industry
15
History
9
$ 5.73Close
$ 3.57 - $ 1.19K 52-Week Range
Ticker Information

Ticker

STSS

Company Name

SHARPS TECHNOLOGY INC

Sector

Healthcare

Industry

Medical Instruments & Supplies

Exchange

NASDAQ

SHARPS TECHNOLOGY INC - Net Cash Flow - Issuance (Purchase) of Equity Shares Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

STSS - CF - Equity Historical data
DateNet Cash Flow - Issuance (Purchase) of Equity Shares
6/30/2025$ 18.58M
3/31/2025$ 21.55M
12/31/2024$ 3.37M
9/30/2024$ 2.97M
6/30/2024$ 7.76M
3/31/2024$ 4.79M
12/31/2023$ 8.03M
9/30/2023$ 8.03M
6/30/2023$ 3.24M
3/31/2023$ 17.44M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • SHARPS TECHNOLOGY INC's latest trailing twelve months (TTM) CF - Equity stands at $ 3.38M.
  • Over the past 5 years, SHARPS TECHNOLOGY INC's average CF - Equity has been $ 9.45M.
  • The median CF - Equity for SHARPS TECHNOLOGY INC during this period was $ 7.9M
  • SHARPS TECHNOLOGY INC reached its highest CF - Equity over the past 5 years at $ 21.55M.
  • The lowest CF - Equity recorded by SHARPS TECHNOLOGY INC in the same timeframe $ 2.97M

SHARPS TECHNOLOGY INC's CF - Equity vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Equity Benchmarks
CompanyCF - Equity
GCTK : GLUCOTRACK INC $ 19.5MHSDT : HELIUS MEDICAL TECHNOLOGIES INC $ 13.18MVIVS : VIVOSIM LABS INC $ 4.41MAIM : AIM IMMUNOTECH INC $ 2.06MHCWB : HCW BIOLOGICS INC $ 6.93MSILO : SILO PHARMA INC $ 3.84MACON : ACLARION INC $ 18.1MPTIX : PROTAGENIC THERAPEUTICS INC $ 6.37MADTX : ADITXT INC $ 44.17MTCRT : ALAUNOS THERAPEUTICS INC $ 0

Definition of Net Cash Flow - Issuance (Purchase) of Equity Shares

[Cash Flow Statement] A component of cash flow from financing [NCFF], representing the cash inflow (outflow) from stock issuance (purchase).

STSS - Net Cash Flow - Issuance (Purchase) of Equity Shares, Last 5 years

$ 2.97M

Minimum

Sep 30, 2024

$ 21.55M

Maximum

Mar 31, 2025

$ 9.45M

Average

$ 7.9M

Median

CF - Equity Benchmark Analysis

The chart above depicts the distribution of CF - Equity for companies in the Total Stock Market. The average CF - Equity of the companies is $ 107.22K with a standard deviation of $ 17.65M.
The following table provides additional summary stats:
CF - Equity in the Market:
filtered constituents2.89K
min$ -60.59M
max$ 60.64M
average$ 107.22K
median$ 0
std$ 17.65M